# Daytime Impact Sleep Study

> **NCT01779466** · PHASE2 · TERMINATED · sponsor: **Ferring Pharmaceuticals** · enrollment: 5 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** Desmopressin
- **DRUG:** Placebo (not active)

## Key facts

- **NCT ID:** NCT01779466
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Terminated due to lack of eligible patients
- **Last updated:** 2015-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779466, "Daytime Impact Sleep Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01779466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*